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High-throughput screening and optimization experiments are crit-
ical to a number of fields, including chemistry and structural and
molecular biology. The separation of these two steps may intro-
duce false negatives and a time delay between initial screening and
subsequent optimization. Although a hybrid method combining
both stepsmay address these problems,miniaturization is required
to minimize sample consumption. This article reports a ‘‘hybrid’’
droplet-based microfluidic approach that combines the steps of
screening and optimization into one simple experiment and uses
nanoliter-sized plugs to minimize sample consumption. Many dis-
tinct reagents were sequentially introduced as 140-nl plugs into
a microfluidic device and combined with a substrate and a diluting
buffer. Tests were conducted in 10-nl plugs containing different
concentrations of a reagent. Methods were developed to form
plugs of controlled concentrations, index concentrations, and in-
cubate thousands of plugs inexpensively andwithout evaporation.
To validate the hybrid method and demonstrate its applicability to
challenging problems, crystallization of model membrane proteins
and handling of solutions of detergents and viscous precipitants
were demonstrated. By using 10 l of protein solution, 1,300
crystallization trials were set up within 20 min by one researcher.
This method was compatible with growth, manipulation, and
extraction of high-quality crystals of membrane proteins, demon-
strated by obtaining high-resolution diffraction images and solv-
ing a crystal structure. This robust method requires inexpensive
equipment and supplies, should be especially suitable for use in
individual laboratories, and could find applications in a number of
areas that require chemical, biochemical, and biological screening
and optimization.
droplets  plugs  protein structure  high-throughput  miniaturization
This work reports a ‘‘hybrid’’ microfluidic approach that usesnanoliter plugs to perform screening and optimization si-
multaneously in the same experiment. To validate this method
using a challenging problem, we demonstrate its compatibility
with crystallization of membrane proteins. Small-scale screening
and optimization experiments are important for biological as-
says, chemical screening, and protein crystallization (1–3).
Screening and optimization are usually carried out sequentially.
In the case of protein crystallization, random sparse matrix
screening initially identifies the precipitants that may lead to
crystallization. Subsequent gradient optimization establishes
concentrations of these precipitants that lead to diffraction-
quality crystals (4). Combining screening and optimization steps
into a single hybrid experiment would eliminate the need to wait
for the outcome of the initial screen before carrying out subse-
quent optimizations. Furthermore, a hybrid experiment would
reduce the false negatives (5) associated with screens performed
at a single concentration. The hybrid experiment could also be
more conclusive, because a single batch of the sample would be
used for both screening and optimization. Simultaneous screen-
ing and optimization could increase consumption of samples, so
miniaturization is essential for the success of the hybrid method.
Such a hybrid method could be especially valuable for the
crystallization of membrane proteins.
Determining crystal structures of membrane proteins is the
focus of major research efforts, with significant recent progress
(6–10). Membrane proteins control a number of cellular signal-
ing pathways and are targets of 50% of pharmaceutical drugs
(11, 12). Crystallization of membrane proteins remains chal-
lenging (13, 14), because samples are often limited in quantity
(15) and may be unstable over time. Also, an extensive range of
crystallization conditions must be searched, including screening
detergents used to solubilize membrane proteins (15–17). Tech-
nologies for miniaturization of crystallization experiments are
needed, but handling solutions of membrane proteins is com-
plicated by their low surface tension and high viscosity. To
address these challenges, both robotic (18, 19) and microfluidic
(20–23) technologies have been developed to screen crystalli-
zation conditions on a submicroliter scale for both soluble and
membrane proteins, but no universally applicable technology has
yet emerged. Given the complexity of the problem of crystalli-
zation of membrane proteins, it is unlikely that a single tech-
nology would provide a universal solution, but there is a clear
need for miniaturized technologies sufficiently robust, simple,
and inexpensive to be accessible to individual laboratories.
Results
Developing a Plug-Based Hybrid Screening Method. To perform
simultaneous hybrid screening and optimization, we used plugs
[droplets surrounded by fluorinated carrier fluid and trans-
ported through microfluidic channels (24)]. Plugs have been
used to perform the initial screening in a number of applications,
including biochemical assays (25), chemical reactions (26), and
crystallization of soluble proteins (22). In separate experiments,
plugs have been used for optimization of protein crystallization
conditions (23). Implementation of the hybrid method while
minimizing sample consumption and labor was enabled by four
key developments (Fig. 1):
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(i) To deliver many distinct reagents in the same experiment,
as required for the initial screen, we used a preformed array
of reagent plugs, each plug 120–140 nl in volume. Each
pair of plugs in the array was separated by40-nl spacer to
ensure reliable transport of reagent plugs of different
viscosities and surface tensions (22, 27). As this array was
flowed from the cartridge into the microfluidic device, each
plug formed a long segment that could be manipulated as
a continuous stream (Fig. 1a). This stream was combined
with the streams of buffer (24) and substrate at a microflu-
idic junction. The three streams flowed continuously and
laminarly into a flowing stream of fluorinated carrier fluid,
forming a series of50 small plugs (10–15 nl) as each 140-nl
plug of reagent combined with buffer and substrate. An
array of 20 reagents produced 1,000 small plugs.
(ii) For each reagent, to accomplish an optimization simulta-
neously with the initial screen, each of 50 small plugs
contained a different concentration of the reagent.We used
a LabView subroutine for computer-controlled pumps to
vary the relative flow rates of the three streams, producing
plugs containing different ratios (and different concentra-
tions) of the reagent, buffer, and substrate (Fig. 1b). When
the flow rates were changed in steps, each step produced a
group of plugs with similar concentration. Higher flow rate
of a stream corresponded to a proportionally higher con-
centration of that stream in the plug (Fig. 1c). Even with
simple syringe pumps, concentrations may be controlled
reliably over a 16-fold range (28).
(iii) To ensure that the optimization covers a full range of
concentrations of each reagent, two approaches are pos-
sible. In the first, the arrival of each reagent plug is
synchronized with the start of a computer subroutine that
gradually changes the f low rate. Although such synchro-
nization is possible when the volumes of reagents and
spacers are known precisely, it complicates the procedure
significantly and is not robust. We used the second
approach, in which the subroutine gradually changes the
f low rate of the reagent up and down and then repeats the
cycle [see supporting information (SI) Fig. 5]. No syn-
chronization was required in this approach as long as each
reagent produced small plugs over a period longer than
one up/down cycle, regardless of where the cycle started;
Fig. 1. Microfluidic approach to perform hybrid screening. (a) Schematic illustration of the approach. A preformed array of140-nl reagent plugs separated
by40-nl spacers is flowed into the microfluidic channel. The stream is combined with streams of buffer and substrate and flowed into a stream of a fluorinated
carrier fluid. For each reagent,50 smaller (10–15 nl) plugs are formed, each potentially containing a different concentration of the reagent. This concentration
may be deduced from the size of the plug. (b) To form plugs containing different concentrations of reagents, the relative flow rates of the three streams are
constantly changed to combine streams in several ratios (black arrows). At the same time, to index these concentrations, the sizes of plugs are changed by
changing the flow rate of the carrier fluid (black arrows). Higher concentrations correspond to smaller plugs. (c) Microphotographs of plugs forming in hybrid
screens, illustrated with plugs colored with dyes. Viscosities of solutions: 36 mPa s (red), 6 mPa s (blue), 1 mPa s (green). (d) A plot quantifying a hybrid screen,
performed in a separate experiment. Precipitants were the same as in cbut marked with fluorescent dyes instead of absorption dyes. Relative (Rel.) concentrations
inside the plugs and sizes of plugs were measured from quantitative fluorescent images. The flow rate of the substrate was kept constant at 10 nl/s. The flow
rates of the reagent and buffer streams were cycled with opposite phases from 10 nl/s to 3.3 nl/s in 1.7-nl/s steps, with each step taking 1.5 s. At the same time,
the flow rate of the carrier fluid was cycled between 23.3 nl/s to 50 nl/s, in 6.7-nl/s steps, in phase with the reagent stream.
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each reagent produced at least one small plug of each
concentration (Fig. 1d). A cycle with a gradual increase
and an abrupt decrease is less redundant and saves
substrate, but we found that abrupt changes of f low rate
were more difficult to control precisely, possibly because
of elasticity of poly(dimethlysiloxane) (PDMS). In addi-
tion, 2-fold redundancy (Fig. 1d) of this method pro-
vided an internal check of reproducibility.
(iv) To index the concentration of reagents in hundreds of plugs
generated by this method, we relied on sensitivity of the size
of the plug to the ‘‘water fraction’’ (29), the ratio of the
combined volumetric f low rates of the aqueous streams to
the total f low rate of the carrier fluid and the aqueous
streams. At higher water fractions, larger plugs form (29).
As the computer subroutine increased the relative flow rate
of the reagent stream, it also decreased the flow rate of the
buffer to keep the combined volumetric f low rates of
the three aqueous streams constant. At the same time, the
subroutine increased the flow rate of the carrier fluid,
decreasing the water fraction and decreasing the size of the
plugs. Within a series of 40 plugs containing the same
reagent, the concentration of a reagent in each plug was
inferred by measuring the size of the plug relative to the size
of plugs in the beginning and the middle of the up/down
cycle (Fig. 1 c and d). The size of plugs changes approxi-
mately linearly with water fraction, and we found the
dependence to be slightly sensitive to viscosity (SI Fig. 6).
Calibration would be required for very accurate measure-
ments of concentrations directly from sizes of plugs. To
identify which series of plugs contained which reagent, we
relied on plugs of the spacer fluid separating these series of
plugs.
Implementing the Hybrid Method to Handle Solutions of Membrane
Proteins. We chose crystallization of membrane proteins to
validate this hybrid approach. We chose this problem both
because of its relevance and the challenges in fluid handling it
presents. This validation was enabled by two technical develop-
ments: the use of perfluoroamines as carrier fluids and the use
of Teflon capillaries for the formation, transport, and storage of
plugs (Fig. 2).
Formation of plugs occurs at low values of the dimensionless
capillary number, Ca  U/, where U (ms1) is the f low
velocity,  (kgm1s1) is the dynamic viscosity, and  (kgs2)
is the surface tension at the interface between the aqueous
phase and the carrier f luid (30). Perf luoroalkane-based carrier
f luids, previously used for crystallization of soluble proteins
(23), did not support formation of plugs of solutions contain-
ing membrane proteins and detergents. The high viscosity and
low surface tension of these solutions increased the value of Ca
above the usable range of Ca  0.1. We were able to control
the surface chemistry at the aqueous–f luorous interface (31)
by identifying two perf luoroamines, FC-40 (a mixture of
perf luoro-tri-n-butylamine and perf luoro-di-n-butylmethyl-
amine) and FC-70 (perf luorotripentylamine), that provided a
sufficiently high surface tension of 10–12 mN/m with the
typical detergent solutions [e.g., 0.1% (wt/vol) lauryldimeth-
ylamine oxide (LDAO)].
To transport plugs through microchannels, the carrier fluid
must wet the walls of the microchannels preferentially. Native
PDMS surfaces did not support formation of plugs, because
solutions of detergents wet them. Microchannels with either
PDMS surfaces modified with a fluorinated silane (31) or native
Teflon surfaces can be used to form plugs, because they are
preferentially wet by FC-40 and FC-70. To form plugs, we used
a thin-walled Teflon capillary, cut at an angle and inserted from
the outlet of the PDMS device up to the plug-forming junction
(Fig. 2a). Plugs formed without contacting the PDMS walls of
the channel and flowed directly into the Teflon capillary (Fig.
2b). Plugs flowed reliably through long (1 m) Teflon capillar-
ies, because flow of plugs through channels of circular cross-
section minimizes drainage of the carrier fluids and undesired
coalescence of plugs (32, 33).
For short-term incubation, we used a 1-m-long capillary to
store 1,000 crystallization trials in a compact format and at a
cost of1 cent per trial (Fig. 2c). Both the carrier fluid and water
evaporated through 25-m thin walls of amorphous Teflon, with
a loss of 48% of water over 12 days. This evaporation could be
used to increase the concentration of the components inside
plugs to drive crystallization (20, 23) in analogy to a vapor-
diffusion trial. For long-term incubation, Teflon capillaries were
placed inside glass tubes (Fig. 2d) filled with the carrier fluid,
reducing evaporation of the aqueous phase to below detection
limit (0.5%) over 60 days. Switching between incubation with
and without glass tubing allows one to stop and start evaporation
at will or to perform crystallizations under microbatch (34)
conditions.
We quantified the formation of plugs in the hybrid method by
using reaction center (RC) from Rhodopseudomonas viridis (7.0
mg/ml) in a solution of LDAO [0.05% (wt/vol) in 10 mM Tris,
pH 7.8]. Three aqueous reagents with viscosities ranging from
1 mPa s (water) to 6 mPa s [50% glycerol (wt/wt)] to 36
mPa s [25% (wt/vol) PEG 8000] were used to mimic the
viscosities of common precipitants. To visualize the hybrid
method, we added absorption dyes to these solutions (Fig. 1c).
To measure concentrations quantitatively (standard dilution
curves shown in SI Fig. 7), we used fluorescent dyes (Fig. 1d) but
used a solution of LDAO instead of RC, because fluorescence
of RC obscured the fluorescence of dyes. For all solutions,
regardless of viscosity, increasing concentrations of precipitants
corresponded to decreasing sizes of plugs, as expected (Fig. 1 c
and d).
Before setting up crystallization trials in a particular deter-
gent, the detergent was added to the precipitants in the screen
and to the buffer. We found that detergents could be lost from
solutions upon contact with hydrophobic PDMS. We have not
Fig. 2. Microfluidic devices for forming and storing plugs of solutions of
membrane proteins in aqueous detergents. (a) Microphotograph of an empty
four-inlet PDMS device coupled to Teflon capillary. (b) Microphotograph of
plugs of an aqueous solution of detergent [0.1% (wt/vol) LDAO in water]
forming directly into a piece of Teflon capillary. (c) A photograph of 1,000
plugs stored in a 1-m-long piece of Teflon capillary wound around a dime. (d)
Photograph of plugs inside Teflon capillary stored in a glass capillary filled
with FC-70 to prevent evaporation of solutions and allow long-term storage.






yet established whether these losses occur by adsorption to the
surface, or by absorption into PDMS. We found that losses were
significant when submicroliter volumes of solutions of detergents
with a low critical micelle concentration (CMC), such as n-
dodecyl--D-Maltopyranoside [CMC 0.17 mM (0.0087%) in
water], were flowed through 1 cm of a PDMS microfluidic
channel. To reduce these losses, we used short inlet channels in
PDMS devices. In addition, when using detergents with a low
CMC, we primed the inlet channels with a solution of this
detergent. Solutions of detergents with higher CMC, such as
LDAO [CMC 1 mM (0.023%) in water] did not require
priming. Once the solutions formed plugs in Teflon capillary, the
layer of fluorinated carrier fluid surrounding the plugs pre-
vented the loss of detergent to hydrophobic surfaces.
We performed hybrid crystallization screens under micro-
batch conditions (without evaporation) by using a custom-made
screening kit of 48 precipitants with concentrations approxi-
mately twice those used in traditional vapor-diffusion screens.
We measured the solubility of typical precipitants in FC-40 and
FC-70 using NMR (SI Table 1) and established that detergents
and some alcohols (such as ethanol and 2R,3R-butanediol) had
solubilities of102M [0.02% (vol/vol)]. Ethanol was themost
soluble at 8.5  103 M in FC-40. We concluded that the loss of
these detergents and precipitants into the carrier fluids should
not significantly affect the crystallization experiments.
Testing Compatibility of the Hybrid Method with Crystallization of
Model Membrane Proteins.We used two model proteins to test the
compatibility of the hybrid method with membrane protein
crystallization. By obtaining high-resolution diffraction of crys-
tals of these proteins, we wished to confirm that all technical
hurdles were identified and overcome successfully. To test
handling of precipitants with high viscosity, we used 3.5 l of
Porin from Rhodobacter capsulatus [29.8 mg/ml in 0.6% (wt/vol)
n-octyltetraoxyethylene (C8E4) and 20 mM Tris pH 7.8]. We
used a viscous precipitant with viscosity of 250 mPa s [con-
taining 70% (wt/vol) PEG 550MME and 3 M LiCl] chosen to
approximate reported (35) crystallization conditions. We used
two plugs of this precipitant in a hybrid screen together with
seven other precipitants (SI Table 2). Using 3.5 l of the protein,
starting with a premade array of precipitant plugs, we set up
450 crystallization trials in 6 min. Only the smallest plugs [30%
(wt/vol) PEG 550MME, 1.9% (wt/vol) C8E4, and 1.3 M LiCl]
produced Porin crystals, whereas plugs of lower concentration
(larger size) were all clear. Crystals (Fig. 3b) formed in both
series of plugs containing PEG 550MME, confirming that fluid
handling was performed correctly and that the system was
compatible with crystallization of this protein.
To test whether the conditions could be scaled up to obtain
larger crystals, we repeated the screen in a larger device fitted
with a silanized glass capillary 600 m in diameter. Larger plugs
gave larger crystals (Fig. 3c). In situ x-ray data collection (36–38)
directly in capillaries was carried out at 4°C by using synchrotron
radiation. Single shots showed that the Porin crystals diffracted
up to 1.95 Å (Fig. 4a) with mosaicity 0.3°, establishing that
crystals of high-quality could be formed and that these crystals
could be manipulated in plugs without any damage.
Fig. 3. Hybrid screens of crystallization conditions for membrane proteins, illustrated with two model proteins. (a) Microphotographs of two regions in a Teflon
capillary containing plugs from a hybrid screen performed for RC from R. viridis [provided by Nina Ponomarenko and James R. Norris (University of Chicago)].
As the concentration of one precipitant is increased (Left), a transition is observed from slight precipitation to large, single crystals to small microcrystals. For
another precipitant (Right), a transition from precipitation to phase separation is seen. (b) An initial small crystal obtained in a hybrid screen of Porin from R.
capsulatus (protein provided by the Philip D. Laible group at Argonne National Laboratory). (c) Larger crystals of Porin were obtained by scaling up the trials
into 600-m glass capillaries. (Scale bars: 100 m.)
Fig. 4. Using x-ray diffraction to characterize quality of crystals of model
membrane proteins obtained with the hybrid method. (a and b) High-
resolution parts of a diffraction pattern of Porin from R. capsulatus (a) and RC
from R. viridis (b). The average signal-to-noise (S/N) ratio exceeds 10 for the
row of reflections centered at 1.95 Å and 1.9 Å for Porin (a) and RC (b) crystals,
respectively. (c) Structure of RC from R. viridis (refined at 1.96-Å resolution)
obtained from crystals grown with the hybrid method.
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We conducted a hybrid screen of RC (22 mg/ml/0.08%
LDAO/7% heptane-triol/4.5% triethylammonium phosphate so-
lution in 20mMNa2HPO4/NaH2PO4 buffer, pH 6.0) using a total
of 20 reagent plugs of 18 precipitants (SI Table 3). In addition
to 16 precipitants from the custom-made kit, we used 2 precip-
itants, both in duplicate plugs: one was a positive control based
on the original crystallization condition (39, 40) [4M (NH4)2SO4
in 50 mM Na2HPO4/NaH2PO4 buffer pH 6.0], and another was
a modified crystallization condition at higher pH [3.6 M
(NH4)2SO4 in 50 mM Tris, pH 7.8]. The duplicates were placed
at random positions within the array of precipitants. By using 10
l of protein for these 18 precipitants, 1,300 crystallization trials
were set up within 20 min. Both the positive control and the
modified condition induced crystallization. As the concentration
of the ammonium sulfate increased from plug to plug (detected
by the decrease in the sizes of plugs), we observed the expected
trend: a mixture of the protein solution with light precipitation,
progressing to single crystals, and then progressing to microc-
rystals (Fig. 3a). Reagents that did not lead to crystals also
showed characteristic transitions. For example, PEG 6000-based
precipitant caused precipitation at low concentrations, whereas
it caused phase separation at higher concentrations (Fig. 3a).
The transition was reproducible within pairs of duplicates,
confirming the correlation between size and concentration as
well as a lack of cross-contamination.
We assessed the quality of the crystals of RC obtained in a
hybrid screen and tested the compatibility of this method with
cryocrystallography. Crystals were slowly (to reduce shear)
flowed out of the Teflon capillary and into a solution of paraffin
oil as the cryoprotectant. We did not observe any crystals
adhering to the walls of the Teflon capillary, presumably because
of the layer of the fluorinated carrier fluid separating the plugs
from the wall (24, 36). Crystals were then looped and flash-
frozen in liquid nitrogen. X-ray data were collected at 100 K by
using synchrotron radiation. The RC crystal grown at the original
conditions (pH 6.0) diffracted up to 2.5 Å. Before data collec-
tion, this crystal was stored in Teflon capillary surrounded by
FC-70 in a glass capillary for 2 months, confirming that
long-term storage of crystals in plugs does not damage them. The
modified condition (pH 7.8) gave better crystals, diffracting to
1.9 Å (Fig. 4b). Two of these crystals were used to collect a
complete (96.5%) x-ray data set. Because of radiation damage,
the resolution cutoff was 1.96 Å. The average mosaicity was
0.3°. The RC structure was refined to R factor of 17.2% (Rfree
18.6%) with well defined electron density for protein and solvent
parts of the structure (Fig. 4c). This experiment confirmed that
high-quality crystals can be grown directly in10-nl plugs of the
hybrid screen and extracted from the capillary without damage
for traditional data collection at cryogenic temperatures.
Discussion
Themicrofluidic hybrid method described in this article provides
a simple and economical procedure for simultaneous screening
and optimization in nanoliter volumes. The use of plugs simpli-
fies this approach: multiple distinct reagents are introduced
serially without cross-contamination, reagents and substrate are
combined by using a single passive microfabricated feature (a
junction of channels), producing hundreds of plugs, with each
plug representing an independent experiment. These plugs are
flowed into an inexpensive piece of capillary and stored and
monitored there without evaporation or damage to crystals.
Overall, we found this method to be effective and now routinely
use it in our laboratory. Within 1 h, using simple syringe pumps
and only 17 l of a substrate solution, a single researcher has set
up a hybrid screen for 48 different reagents (40 plugs per
reagent) to sample a total of 1,900 experimental conditions.
We expect this method to operate on smaller scales as well,
because the capillary number that governs fluid flow in these
systems is not explicitly sensitive to the dimensions of the
channels or plugs. Such miniaturization would require arrays of
reagents in smaller plugs (41) and reliable pumping at lower flow
rates.
A volume of10 nl proved to be the optimal volume for plugs
used for crystallization of model membrane proteins: it saved
sample but contained enough protein to produce crystals of
sufficient size and quality for high-resolution diffraction. Ex-
tracting and manipulating crystals grown in plugs was also
straightforward, making this system compatible with both cryo
(4) and in situ (36–38) x-ray diffraction. This method overcame
the challenges associated with handling of solutions of mem-
brane proteins and provided control of wetting, evaporation, and
loss of detergents. Here, we have shown that this hybrid method
is compatible with crystallization of membrane proteins. To
establish its ultimate usefulness, one would need to screen a
panel of 20–30 new, but biochemically well characterized, mem-
brane proteins. Our laboratory does not yet have access to such
a panel of proteins, but there is a significant effort to produce
them under the Protein Structure Initiative and under the
National Institutes of Health Roadmap (www.nigms.nih.gov/
Initiatives/PSI/Centers/ and http://nihroadmap.nih.gov/structur-
albiology/index.asp). We welcome both disseminating this tech-
nology and receiving such panels of samples for testing in our
laboratory.
Having successfully handled solutions of membrane proteins,
it was not surprising that this method had no problems handling
aqueous solutions free of detergents. We have used this method
to implement crystallization screens with commercial kits from
Hampton Research (Aliso Viejo, CA) and Emerald Biostruc-
tures (Bainbridge Island, WA). We do not anticipate problems
performing enzymatic assays with this method (22, 28), but it
remains to be established whether this method is compatible
with screening of samples containing live cells, an area that could
also benefit from a nanoliter hybrid screen. We used optical
detection in all of the experiments, by using a microscope
scanning stage or by pulling the capillary with plugs through the
microscope’s field of view. This method would benefit from
simple automated systems for detection in plugs, either optical
or based on mass spectrometry (26). Beyond crystallization, we
believe this method would find applications in a number of areas
(5, 42–46) of chemistry, biochemistry, molecular biology, and
material science that require simultaneous screening and opti-
mization economically and in small volumes.
Materials and Methods
See SI Supporting Text for detailed procedures and additional
characterizations and control experiments.
Microfluidic Hybrid Experiments. Preformed arrays (41) and mi-
crofluidic devices (28, 31) were prepared as described previ-
ously, by using mask design and dimensions as in SI Fig. 8. A
Teflon capillary (OD 250 m, i.d. 200 m; Zeus, Orangeburg,
SC), cut at an angle (45°) to facilitate the transfer of plugs, was
inserted into the junction of microchannels of the hybrid device
through the outlet microchannel. Connections of Teflon and
PDMS were sealed with capillary wax (Hampton Research).
Teflon capillaries outside the PDMS device were put in standard
wall glass tubing (Chemglass, Vineland, NJ) filled with FC-70
(Acros Organics, Morris Plains, NJ) to prevent evaporation. The
ends of the glass tubing were sealed with capillary wax. Aqueous
phases and carrier fluids were loaded into 1700 series Gastight
syringes (Hamilton, Reno, NV) with removable 27-gauge nee-
dles and 30-gauge Teflon tubing (Weico Wire & Cable, Edge-
wood, NY). Protein was loaded into syringes with no losses (SI
Fig. 9). PHD 2000 infusion syringe pumps (Harvard Apparatus,
Hollistion, MA) controlled with a custom LabView subroutine






were used to drive flows (subroutine provided in SI Supporting
Text).
Crystallization of RC from R. viridis and Porin from R. capsulatus.
Crystallization details are in the SI Tables 2 and 3.
X-Ray Diffraction and Structure Determination. X-ray data collec-
tion details are given in SI Table 4 and Fig. 10. A detailed flow
chart outlining the procedures for the hybrid experiments is
shown in SI Fig. 11.
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